Condition: Lymphoma, Non-Hodgkin Intervention: Biological: anti-CD19 FasT CAR-T cells Sponsors: Xinqiao Hospital of Chongqing; Gracell Biotechnologies (Shanghai) Co., Ltd; 920th Hospital of Joint Logistics Support Force; The Second Affiliated Hospital of Chongqing Medical University; The Affiliated Hospital Of Guizhou Medical University; The Second Affiliated Ho spital of Kunming Medical University; Chongqing University Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου